IGENETRAIN

iGeneTRAiN is currently combining genetic data from these subjects with the aim of detecting genes and specific variants underpinning rejection. A number of the iGeneTRAiN studies are also working on markers from urine, blood and tissue to predict rejection weeks to months before it manifests clinically... iGeneTRAiN aims to coordinate genetic and other patient biospecimen and clinical datasets, from sites across the world engaged in clinical and research transplant programs. We are well underway in generating massive, integrated datasets that will empower us to identify factors associated with transplant success. Relevant information includes data from clinical, genetic, protein, metabolite, and a range of other studies, including wearable devices... New! PUBLICATION: Early Detection of SARS-CoV-2 and other Infections in Solid Organ Transplant Recipients and Household Members using Wearable

Also known as: iGeneTRAiN Consortium

Primary location: Philadelphia United States